Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Oncy is a Cult Pt. 2

<< Previous

Bullboard Posts

Next >>

Comment by ScootsMcgootson Feb 07, 2024 3:10pm

119 Views

Post# 35868188

RE:RE:Oncy is a Cult Pt. 2

Doesn't ONCY have to PR the closing of SD office and other structural changes? NO PR ON THAT AS WELL. Communication blackout? Companies PR this kind of stuff all the time before a deal is done it has no bearing on a deal whatsoever. We are closing XYZ for ABC reason. It's a public company and they are obligated to communicate this information.

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec